BSE Live
Nov 14, 16:01Prev. Close
799.95
Open Price
795.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 14, 15:59Prev. Close
798.20
Open Price
795.50
Bid Price (Qty.)
803.70 (91)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Orchid Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 921.93 | 816.11 | 656.66 | 556.85 | 449.60 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 921.93 | 816.11 | 656.66 | 556.85 | 449.60 | |
| Total Operating Revenues | 921.93 | 819.37 | 665.90 | 559.56 | 450.06 | |
| Other Income | 27.47 | 30.86 | 19.43 | 9.00 | 15.23 | |
| Total Revenue | 949.40 | 850.23 | 685.33 | 568.56 | 465.29 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 585.46 | 528.35 | 406.10 | 340.62 | 245.60 | |
| Purchase Of Stock-In Trade | 2.61 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FGWIP And Stock In Trade | -43.85 | -43.89 | -21.48 | -27.06 | -17.09 | |
| Employee Benefit Expenses | 86.36 | 69.64 | 65.35 | 63.28 | 67.11 | |
| Finance Costs | 14.54 | 16.35 | 32.23 | 32.01 | 51.34 | |
| Depreciation And Amortisation Expenses | 34.55 | 33.24 | 54.79 | 87.02 | 108.92 | |
| Other Expenses | 174.17 | 154.59 | 132.31 | 129.59 | 104.67 | |
| Total Expenses | 853.84 | 758.29 | 669.29 | 625.46 | 560.54 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 95.56 | 91.95 | 16.04 | -56.90 | -95.25 | |
| Exceptional Items | 0.00 | 0.00 | 39.21 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 95.56 | 91.95 | 55.25 | -56.90 | -95.25 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | -0.10 | -3.23 | 0.00 | 0.00 | 0.00 | |
| Other Direct Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | -0.19 | -3.12 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 95.76 | 95.06 | 55.25 | -56.90 | -95.25 | |
| Profit/Loss From Continuing Operations | 95.76 | 95.06 | 55.25 | -56.90 | -95.25 | |
| Profit/Loss For The Period | 95.76 | 95.06 | 48.47 | 1.57 | -116.53 | |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Consolidated Profit/Loss After MI And Associates | 99.66 | 92.17 | 46.32 | -1.95 | -116.53 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 20.00 | 19.00 | 11.00 | 0.00 | -29.00 | |
| Diluted EPS (Rs.) | 20.00 | 19.00 | 11.00 | 0.00 | -29.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
12.11.2025
Orchid Pharma Standalone September 2025 Net Sales at Rs 193.52 crore, down 13.1% Y-o-Y
09.09.2025
Orchid Pharma Standalone June 2025 Net Sales at Rs 172.93 crore, down 29.25% Y-o-Y
27.05.2025
Orchid Pharma Standalone March 2025 Net Sales at Rs 237.48 crore, up 9.39% Y-o-Y
20.02.2025
Stocks On Radar: HFCL, Waaree Energies, IREDA, Orchid Pharma in focus on 20 February
12.11.2025
Orchid Pharma Standalone September 2025 Net Sales at Rs 193.52 crore, down 13.1% Y-o-Y
09.09.2025
Orchid Pharma Standalone June 2025 Net Sales at Rs 172.93 crore, down 29.25% Y-o-Y
27.05.2025
Orchid Pharma Standalone March 2025 Net Sales at Rs 237.48 crore, up 9.39% Y-o-Y
17.02.2025
Orchid Pharma Standalone December 2024 Net Sales at Rs 217.34 crore, down 1.47% Y-o-Y
12.02.2014